We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Media Formulation Free of Animal Origin

By HospiMedica staff writers
Posted on 23 Jun 2006
A new facility has been validated for production of media formulation in an animal-free environment. More...
Several pharmaceutical and biotechnology clients have already received material manufactured in the facility.

Invitrogen Corporation (Grand Island, NY, USA) has expanded production capabilities of animal-free advanced granulation technology (AGT) media. It plans to transform 11,000 square feet of existing space on its New York campus for production of AGT media for internal projects, internalization of technology for contract manufacturing abilities, and reduction of manufacturing costs.

The company evaluated more than 800 raw materials involved in AGT production and verified that they were free of animal components. It also created protocols for the manufacture and production environment, stringent requirements for staff gowning, contamination controls such as airlocks, irradiation of clothing and tools, as well as separate locker facilities.

The AGT format has a number of advantages compared to dry powder media. AGT media are complete and require no supplementation or pH adjustment, thus decreasing time in large-scale media and buffer preparations. The new format also improves dissolution rates and reduces the generation of dust, keeping preparation areas safer and lessening the chance of cross-contamination. ATG media increase yield while decreasing total cycle costs.



Related Links:
Invitrogen

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
New
Gold Member
Radiology Monitor
MDNC-12130 Barco Nio Fusion 12MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.